Announced Thu, 1 Oct, 2026 · 22:20 IST

All resolutions passed at 18th AGM with 100 percent approval

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.6%Reaction day
₹129.20
prior close
₹135.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-4.6% vs market
Industrial Products peers, median of 135sector-0.5%-4.1% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 4.1 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.6+0.0-4.6-0.5-4.1
Next day
-0.2+1.3-1.5+0.6-0.8
2d
-1.3+1.1-2.4+0.4-1.7
3d
+1.8-1.7+3.5-1.9+3.7
4d
-0.1-1.4+1.3-1.5+1.4
5d
-2.4-0.6-1.8-1.4-1.0
1w
-1.8+0.3-2.1-0.8-0.9
15d
-8.8pendingpending-6.3-2.5
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 135Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gabion Technologies held its 18th AGM on 30 September 2026 via video conferencing. All 4 resolutions passed with 100 percent votes in favor, with 7 members voting representing 63,80,730 shares. Resolutions covered adoption of audited financial statements for FY ending March 2026, re-appointment of Whole Time Director Urvashi Sarda, and appointment of statutory auditor. Total shareholders on record date were 568.

Likely market impact

Routine corporate governance exercise completed smoothly. No major impact on shareholders or stock price expected from these routine approvals.